Health Equity and Decentralized Trials
Authors:
Open Access
- 20 June 2023
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA
- Vol. 329 (23) , 2013-2014
Abstract
This Viewpoint discusses the proliferation of decentralized clinical trials during the COVID-19 pandemic and the need for rigorous studies to inform whether decentralized approaches promote or prevent access to clinical trials for people facing health disparities.Keywords
This publication has 5 references indexed in Scilit:
- Opportunities and counterintuitive challenges for decentralized clinical trials to broaden participant inclusionnpj Digital Medicine, 2022
- Inclusion and diversity in clinical trials: Actionable steps to drive lasting changeContemporary Clinical Trials, 2022
- Remote Research and Clinical Trial Integrity During and After the Coronavirus PandemicJAMA, 2021
- Effects of the COVID-19 Pandemic on Active Non-COVID Clinical TrialsJACC, 2020
- Web-based trial to evaluate the efficacy and safety of tolterodine ER 4mg in participants with overactive bladder: REMOTE trialContemporary Clinical Trials, 2014